Intervention Protocol

You have free access to this content

Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma

  1. Qi Zhang1,
  2. Xue Li Bai1,
  3. Wei Chen1,
  4. Tao Ma1,
  5. Hao Liu1,
  6. Yun Zhang1,
  7. Xiao Jun Hu2,
  8. Ting Bo Liang1,*

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 23 DEC 2013

DOI: 10.1002/14651858.CD010897


How to Cite

Zhang Q, Bai XL, Chen W, Ma T, Liu H, Zhang Y, Hu XJ, Liang TB. Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD010897. DOI: 10.1002/14651858.CD010897.

Author Information

  1. 1

    the Second Affiliated Hospital, School of Medicine, Zhejiang University, Department of Hepatobiliary and Pancreatic Surgery, Hangzhou, Zhejiang Province, China

  2. 2

    Zhejiang University, Center for Medical Information, Hangzhou, China

*Ting Bo Liang, Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, Zhejiang Province, 310009, China. liangtingbo@zju.edu.cn.

Publication History

  1. Publication Status: New
  2. Published Online: 23 DEC 2013

SEARCH

References

Additional references

Altekruse 2009
Begg 1994
Breedis 1954
Brok 2008
  • Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61:763-9. [PUBMED: 18411040]
Brok 2009
  • Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive - Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98. [PUBMED: 18824466]
Bruix 2005
Calvet 1990
Chua 2010
Chuang 1981
CTU 2011
  • Copenhagen Trial Unit. TSA - Trial Sequential Analysis. ctu.dk/tsa/ 2011 (accessed 11 June 2013).
Davila 2004
Di Bisceglie 2010
  • Di Bisceglie AM, Befeler AS. Tumors and cysts of the liver. In: Feldman M, Friedman LS, Brandt LJ editor(s). Feldman: Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 9th Edition. St. Louis: Saunders, 2010:1569-92.
Doyon 1974
  • Doyon D,  Mouzon A,  Jourde AM,  Regensberg C,  Frileux C. Hepatic, arterial embolization in patients with malignant liver tumours. Annales de Radiologie 1974;17(6):593-603. [PUBMED: 4142843]
Egger 1997
Gluud 2013
  • Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al. Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 5. Art. No.: LIVER.
Hassan 2010
Higgins 2004
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hollis 1999
Imamura 2003
Izumi 1994
Kakizaki 1997
  • Kakizaki S, Takagi H, Katakai K, Kanda D, Kosone T, Kojima A, et al. The natural history of untreated hepatocellular carcinoma. International Journal of Clinical Oncology 1997;3(5):299-303. [DOI: 10.1007/BF02628050]
Katz 2009
Kim 2010
  • Kim JH, Yoon HK, Ko GY, Gwon D, Jang CS, Song HY, et al. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 2010;255:270-7. [DOI: 10.1148/radiol.09091076]
Kjaergard 2001
Kurokawa 2006
  • Kurokawa F. Management of the complication after TACE. Kantansui 2006;53(5):795-7.
Lau 2000
Lau 2009
  • Lau WY, Lai EH, Lau SH. The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review. Hepatobiliary & Pancreatic Diseases International 2009;8(2):124-33. [PUBMED: 19357024]
Lee 2002
  • Lee KH, Sung KB, Lee DY, Park SJ, Kim KW, Yu JS. Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics 2002;22(5):1077-91. [PUBMED: 12235337]
Li 1995
Li 2006
  • Li Q, Wang J, Sun Y, Cui YL, Juzi JT, Qian BY, et al. Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: a randomised study with 131 cases. Digestive Surgery 2006;23(4):235-40. [PUBMED: 16943671]
Liapi 2011
Lin 2003
  • Lin SC, Shih SC, Kao CR, Chou SY. Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis. World Journal of Gastroenterology 2003;9(6):1208-11. [PUBMED: 12800225]
Lu 2008
  • Lu X, Zhao HT, Mao YL, Sang XT, Xu YY, Du SD, et al. Early recurrence after the resection of hepatocellular carcinoma. Acta Academiae Medicinae Sinicae 2008;30(4):415-20. [PUBMED: 18795612]
Lui 2011
  • Lui HF. Screening for hepatocellular carcinoma. International Journal of Hepatology 2011;2011:363151. [DOI: 10.4061/2011/363151]
Lundh 2012
Marelli 2006
Marshall 2000
Mathurin 2003
McGlynn 2011
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
Nakashima 1986
Nathan 2009
Okada 2001
Okuda 1985
Oliveri 2011
Otto 1998
  • Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Annals of Surgery 1998;227(3):424-32. [PUBMED: 9527066]
Peng 2009
  • Peng BG, He Q, Li JP, Zhou F. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumour thrombus. American Journal of Surgery 2009;198(3):313-8. [PUBMED: 19285298]
Poon 2000
  • Poon RT, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Annals of Surgery 2000;232:10-24. [PUBMED: PMC1421103]
Poon 2011
Pua 2008
  • Pua U, Wong DE. Transarterial embolisation of spontaneous adrenal pheochromocytoma rupture using polyvinyl alcohol particles. Singapore Medical Journal 2008;49(5):e126-a130. [PUBMED: 18465036]
Rampone 2009
RevMan 2012 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Royle 2003
  • Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
Sakamoto 1998
  • Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, et al. Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 1998;18(3):605-19. [PUBMED: 9599386]
Sanyal 2010
Savović 2012a
  • Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429-38. [PUBMED: 22945832]
Savović 2012b
  • Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment 2012;16(35):1-82. [PUBMED: 22989478]
Schulz 1995
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12. [PUBMED: 7823387]
Siegel 2013
Thorlund 2009
  • Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses. International Journal of Epidemiology 2009;38(1):276-86. [PUBMED: 18824467]
Thorlund 2010
  • Thorlund K, Anema A, Mills E. Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology 2010;2:57-66. [PUBMED: 20865104]
Thorlund 2011
  • Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). ctu.dk/tsa/files/tsa_manual.pdf 2011 (accessed 11 June 2013).
Wetterslev 2008
Wetterslev 2009
WHO 2012
  • World Health Organization. Cause of death 2008 summary tables. www.who.int/gho/mortality_burden_disease/ (accessed 27 June 2013).
Wood 2008
  • Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5.
Yeh 2003
Yeung 2005
  • Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J. Natural history of untreated non-surgical hepatocellular carcinoma. American Journal of Gastroenterology 2005;100(9):1995-2004. [DOI: 10.1111/j.1572-0241.2005.00229.x; PUBMED: 16128944]
    Direct Link:
Zhang 2010
  • Zhang T, Ding X, Wei D, Cheng P, Su X, Liu H, et al. Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomised trials. Anticancer Drugs 2010;21(3):326-32. [PUBMED: 20016366 ]
Zhong 2009
  • Zhong C, Guo RP, Li JQ, Shi M, Wei W, Chen MS, et al. A randomised controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for stage III A hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2009;135(10):1437-45. [PUBMED: 19408012]
Zhong 2010
Zhou 2012